Recent

% | $
Quotes you view appear here for quick access.

OCATA THERAPEUTICS, INC. Message Board

  • nag_ro nag_ro May 6, 2013 10:17 PM Flag

    NASDAQ is proposing new "internal audit" function as mandatory to listing====ACTC should just prove the science.

    The idea of CEO to go to NASDAQ to stop shorts is just BS in my opinion and for the following reasons:

    GR wants to build his own marketability after ACTC.
    GR thinks shorts stop after Listing on NASDAQ.
    GR believes expenses are less under NASDAQ listing rules====dumb assumption by GR.
    GR believes he knows WS regulations but has no idea what is necessary and will make listing and compliance errors.
    GR has no clue about internal controls, SOX light, SEC reporting, CEO 906 certs etc....
    GR has shown me he's a clown and not experienced.

    BASICALLY ACTC HAS GREAT SCIENCE AND LEADERSHIP EXCEPT IN FINANCE, ACCOUNTING AND CEO IS MY OPINION.

    THE WAY FORWARD FOR ACTC IS TO PROVE THE SCIENCE AND FORGET ABOUT PINK SHEET MANIPULATION. APPRECIATION WILL HAPPEN WITH CURE OR MARKETABLE TREATMENT AND THAT'S A FACT REGARDLESS OF PINK SHEET OR NASDAQ LISTING. REVERSE SPLIT BEFORE OR AFTER MAKES ZERO FINANCIAL DIFFERENCE. THIS IS MAINLY AN EGO THING FOR CEO AND ALSO A WAY FOR HIM TO UPGRADE HIS RESUME FOR FUTURE SALE OF HIMSELF AND NOT ACTC.

    SORRY JUST MY VIEW AND I'M TOO OLD TO PUT UP WITH THE BS FROM ANY CORNER OF THE WORLD ANYMORE SO THERE IT IS OUT IN THE OPEN AS MY OPINION AND YOU ALL CAN DO YOUR OWN THINKING AND DILIGENCE.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
ACTC
0.00(0.00%)